Skip to main content
Erschienen in: Supportive Care in Cancer 12/2013

01.12.2013 | Original Article

Cancer pain management in an oncological ward in a comprehensive cancer center with an established palliative care unit

verfasst von: Sebastiano Mercadante, Costanza Guccione, Simona Di Fatta, Valentina Alaimo, Giovanna Prestia, Rosanna Bellingardo, Vittorio Gebbia, Antonino Giarratano, Alessandra Casuccio

Erschienen in: Supportive Care in Cancer | Ausgabe 12/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

This survey was performed to draw information on pain prevalence, intensity, and management from a sample of patients who were admitted to an oncologic center where a palliative care unit (PCU) has been established for 13 years.

Methods

Cross-sectional survey in an oncological department performed 1 day per month for six consecutive months.

Results

Of the 385 patients, 69.1, 19.2, 8.6, and 3.1 % had no pain, mild, moderate, and severe pain, respectively. Inpatients and patients with a low Karnofsky score showed higher levels of pain intensity (p < 0.0005). One hundred twenty-eight patients with pain or receiving analgesics were analyzed for pain management index (PMI). Only a minority of patients had negative PMI score, which was statistically associated with inpatient admission (p = 0.011). Fifty of these 128 patients had breakthrough pain (BTP), and all of them were receiving some medication for BTP.

Conclusion

It is likely that the presence of PCU team providing consultation, advices, and cultural pressure, other than offering admissions for difficult cases had a positive impact on the use of analgesics, as compared with previous similar surveys performed in oncological setting, where a PCU was unavailable. This information confirms the need of the presence of a PCU in a high volume oncological department.
Literatur
1.
Zurück zum Zitat Apolone G, Corli O, Caraceni A et al (2009) Pattern and quality of care of cancer pain management. Results from the Cancer pain outcome research study group. Br J Cancer 100:1566–1574PubMedCrossRef Apolone G, Corli O, Caraceni A et al (2009) Pattern and quality of care of cancer pain management. Results from the Cancer pain outcome research study group. Br J Cancer 100:1566–1574PubMedCrossRef
2.
Zurück zum Zitat Bandieri E, Sichetti D, Romero M, Fanizza C et al (2012) Impact of early access to a palliative/supportive care intervention on pain management in patients with cancer. Ann Oncol 23:2016–2020PubMedCrossRef Bandieri E, Sichetti D, Romero M, Fanizza C et al (2012) Impact of early access to a palliative/supportive care intervention on pain management in patients with cancer. Ann Oncol 23:2016–2020PubMedCrossRef
3.
Zurück zum Zitat Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K (1991) The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7:6–9PubMed Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K (1991) The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7:6–9PubMed
4.
Zurück zum Zitat Bruera E, Hui D (2011) Palliative care units: the best option for the most distressed. Arch Intern Med 171:1601PubMedCrossRef Bruera E, Hui D (2011) Palliative care units: the best option for the most distressed. Arch Intern Med 171:1601PubMedCrossRef
5.
Zurück zum Zitat Cascinu S, Giordani P, Agostinelli R et al (2003) Pain and its treatment in hospitalized patients with metastatic cancer. Support Care Cancer 11:587–592PubMedCrossRef Cascinu S, Giordani P, Agostinelli R et al (2003) Pain and its treatment in hospitalized patients with metastatic cancer. Support Care Cancer 11:587–592PubMedCrossRef
6.
Zurück zum Zitat Cherny NI, Baselga J, de Conno F, Radbruch L (2009) Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Europe: a report from the ESMO/EAPC Opioid Policy Initiative. Ann Oncol 21:615–626CrossRef Cherny NI, Baselga J, de Conno F, Radbruch L (2009) Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Europe: a report from the ESMO/EAPC Opioid Policy Initiative. Ann Oncol 21:615–626CrossRef
7.
8.
Zurück zum Zitat Cleeland CS, Portenoy RK, Rue M et al (2005) Does an oral analgesic protocol improve pain control for patients with cancer? An intergroup study coordinated by the Eastern cooperative oncology group. Ann Oncol 16:972–980PubMedCrossRef Cleeland CS, Portenoy RK, Rue M et al (2005) Does an oral analgesic protocol improve pain control for patients with cancer? An intergroup study coordinated by the Eastern cooperative oncology group. Ann Oncol 16:972–980PubMedCrossRef
9.
Zurück zum Zitat Cleeland CS, Gonin R, Hatfield AK et al (1994) Pain and its treatment in outpatients with metastatic cancer. N Eng J Med 330:592–596CrossRef Cleeland CS, Gonin R, Hatfield AK et al (1994) Pain and its treatment in outpatients with metastatic cancer. N Eng J Med 330:592–596CrossRef
10.
Zurück zum Zitat Deandrea S, Montanari M, Moja L et al (2008) Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol 19:1985–1991PubMedCrossRef Deandrea S, Montanari M, Moja L et al (2008) Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol 19:1985–1991PubMedCrossRef
11.
Zurück zum Zitat Di Maio M, Gridelli C, Gallo C et al (2004) Prevalence and management of pain in Italian patients with advanced non-small cell lung cancer. Br J Cancer 90:2288–2296PubMed Di Maio M, Gridelli C, Gallo C et al (2004) Prevalence and management of pain in Italian patients with advanced non-small cell lung cancer. Br J Cancer 90:2288–2296PubMed
12.
Zurück zum Zitat De Conno F, Ripamonti C, Brunelli C (2005) Opioid purchases and expenditure in nine western European countries: are we killing off morphine? Palliat Med 19:179–184PubMedCrossRef De Conno F, Ripamonti C, Brunelli C (2005) Opioid purchases and expenditure in nine western European countries: are we killing off morphine? Palliat Med 19:179–184PubMedCrossRef
13.
Zurück zum Zitat Marino I. Attuazione della legge 15.03.2010, n. 38 in materia di “terapia del dolore” presso le strutture ospedaliere. Commissione parlamentare di inchiesta sull’efficacia e l’efficienza del SSN. Italian Parliament. Marino I. Attuazione della legge 15.03.2010, n. 38 in materia di “terapia del dolore” presso le strutture ospedaliere. Commissione parlamentare di inchiesta sull’efficacia e l’efficienza del SSN. Italian Parliament.
14.
Zurück zum Zitat Mercadante S (2007) Why are our patients still suffering pain? Nat Clin Pract Oncol 4:138–139PubMedCrossRef Mercadante S (2007) Why are our patients still suffering pain? Nat Clin Pract Oncol 4:138–139PubMedCrossRef
15.
Zurück zum Zitat Mercadante S (1999) Pain treatment and outcome in advanced cancer patients followed at home. Cancer 85:1849–1858PubMedCrossRef Mercadante S (1999) Pain treatment and outcome in advanced cancer patients followed at home. Cancer 85:1849–1858PubMedCrossRef
16.
Zurück zum Zitat Mercadante S, Fulfaro F (2005) World Health Organization guidelines for cancer pain: a reappraisal. Ann Oncol 16(Suppl 4):132–135 Mercadante S, Fulfaro F (2005) World Health Organization guidelines for cancer pain: a reappraisal. Ann Oncol 16(Suppl 4):132–135
17.
Zurück zum Zitat Mercadante S, Vitrano V (2010) Palliative care in Italy: problem areas emerging from the literature. Minerva Anestesiol 76:1060–1071PubMed Mercadante S, Vitrano V (2010) Palliative care in Italy: problem areas emerging from the literature. Minerva Anestesiol 76:1060–1071PubMed
18.
Zurück zum Zitat Mercadante S, Roila F, Berretto O, Labianca R, Casilini S; DOMAIN-AIOM study group (2008) Prevalence and treatment of cancer pain in Italian oncological wards centres: a cross-sectional survey. Support Care Cancer 16:1203–1211CrossRef Mercadante S, Roila F, Berretto O, Labianca R, Casilini S; DOMAIN-AIOM study group (2008) Prevalence and treatment of cancer pain in Italian oncological wards centres: a cross-sectional survey. Support Care Cancer 16:1203–1211CrossRef
19.
Zurück zum Zitat Mercadante S, Villari P, Ferrera P (2003) A model of acute symptom control unit: pain relief and palliative care unit of La Maddalena Cancer Center. Support Care Cancer 11:114–119PubMed Mercadante S, Villari P, Ferrera P (2003) A model of acute symptom control unit: pain relief and palliative care unit of La Maddalena Cancer Center. Support Care Cancer 11:114–119PubMed
20.
Zurück zum Zitat Mercadante S, Villari P, Casuccio A (2011) An Italian survey on the attitudes in treating breakthrough cancer pain in hospice. Support Care Cancer 19:979–983PubMedCrossRef Mercadante S, Villari P, Casuccio A (2011) An Italian survey on the attitudes in treating breakthrough cancer pain in hospice. Support Care Cancer 19:979–983PubMedCrossRef
21.
22.
Zurück zum Zitat Mercadante S (2013) Opioid consumption depends on early palliative care in Italy. Ann Oncol 24:558PubMedCrossRef Mercadante S (2013) Opioid consumption depends on early palliative care in Italy. Ann Oncol 24:558PubMedCrossRef
23.
Zurück zum Zitat Mercadante S, Prestia G, Ranieri M, Giarratano A, Casuccio A (2013) Opioid use and effectiveness of its prescription at discharge in an acute pain relief and palliative care unit. Support Care Cancer 21:1853–1859PubMedCrossRef Mercadante S, Prestia G, Ranieri M, Giarratano A, Casuccio A (2013) Opioid use and effectiveness of its prescription at discharge in an acute pain relief and palliative care unit. Support Care Cancer 21:1853–1859PubMedCrossRef
24.
Zurück zum Zitat Moro C, Brunelli C, Miccinesi G, Fallai M et al (2006) Edmonton symptom assessment scale: Italian validation in two palliative care settings. Support Care Cancer 14:30–37PubMedCrossRef Moro C, Brunelli C, Miccinesi G, Fallai M et al (2006) Edmonton symptom assessment scale: Italian validation in two palliative care settings. Support Care Cancer 14:30–37PubMedCrossRef
25.
Zurück zum Zitat Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS (1995) When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 61:277–284PubMedCrossRef Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS (1995) When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 61:277–284PubMedCrossRef
26.
Zurück zum Zitat Ripamonti C, Zecca E, Brunelli C et al (2000) Pain experienced by patients hospitalized at the national cancer institute of Milan: research project “towards a pain-free hospital”. Tumori 86:412–418PubMed Ripamonti C, Zecca E, Brunelli C et al (2000) Pain experienced by patients hospitalized at the national cancer institute of Milan: research project “towards a pain-free hospital”. Tumori 86:412–418PubMed
27.
Zurück zum Zitat Ripamonti C, Bandieri E, Roila F (2011) Management of cancer pain: ESMO clinical practice guidelines. Ann Oncol 22(Suppl 6):69–77 Ripamonti C, Bandieri E, Roila F (2011) Management of cancer pain: ESMO clinical practice guidelines. Ann Oncol 22(Suppl 6):69–77
28.
Zurück zum Zitat Van den Beuken-van Everdingen MHJ, De Rijke JM, Kessels AG et al (2007) Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 18:1437–1449PubMedCrossRef Van den Beuken-van Everdingen MHJ, De Rijke JM, Kessels AG et al (2007) Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 18:1437–1449PubMedCrossRef
Metadaten
Titel
Cancer pain management in an oncological ward in a comprehensive cancer center with an established palliative care unit
verfasst von
Sebastiano Mercadante
Costanza Guccione
Simona Di Fatta
Valentina Alaimo
Giovanna Prestia
Rosanna Bellingardo
Vittorio Gebbia
Antonino Giarratano
Alessandra Casuccio
Publikationsdatum
01.12.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 12/2013
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-013-1899-z

Weitere Artikel der Ausgabe 12/2013

Supportive Care in Cancer 12/2013 Zur Ausgabe

Letter to the editor

Reply to Molassiotis

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.